|
|
 |
Discovery, development and commercialization of druts to treat neurological diseases and disorders |
IPO |
2004 |
|
|
|
 |
Proprietary technologies for the early detection, monitoring and staging of common cancers |
IPO |
2001 |
|
|
|
Anesta Corporation |
Powerful drug system to control the severe pain of end stage cancer |
Acquired |
2000 |
 |
|
|
 |
Discovery, development and commercialization of prescription pain management products |
IPO |
2000 |
|
|
|
 |
Pharmaceuticals for treatment of metabolic diseases and endocrine disorders |
IPO |
2000 |
|
|
|
 |
Developmental biology insights for regenerative medicine therapies |
Acquired |
2000 |
 |
|
|
 |
Technology and products to treat cancers, infectious diseases, and autoimmune disorders |
IPO |
2000 |
|
|
|
 |
Sequenced human genome; now focused on therapeutics for cancer and other diseases |
IPO |
2000 |
|
|
|
AudioLogic, Inc. |
High performance digital signal processing systems |
Acquired |
1999 |
 |
|
|
Somatogen |
Synthetic hemoglobin products for use in blood transfusion |
Acquired |
1998 |
 |
|
|
 |
Developer of high-technology purification, analysis and synthesis products |
Acquired |
1998 |
 |
|
|
ChemGenics Pharmaceuticals |
Genetically directed drug discovery focused on fungal bacterial diseases |
Acquired |
1997 |
 |
|
|
 |
Design, development, manufacturing, and marketing of medical devices focused on women's health |
IPO |
1996 |
|
|
|
 |
Products that enhance the ability of veterinarians to economically provide advanced medical care |
IPO |
1991 |
|
